Latest News- Kidney Stones Therapeutic Market: Hospitals expected to lead the End-user segment during 2025-2029

The Kidney Stones Therapeutic Market is being driven by Growing popularity of flexible digital ureteroscopes

The Kidney Stones Therapeutic Market is expected to grow at a CAGR of 5.1% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 582.9 million. In the kidney stones therapeutic market, ongoing research is driving innovation and advancements in treatment procedures. Over the past three decades, significant strides have been made, with the introduction of lithotripsy, enhanced URS, and percutaneous techniques, which have largely supplanted conventional open surgical methods. Holmium laser technology has been a game-changer, enabling efficient stone removal through URS with minimal damage to surrounding tissues, thereby increasing its widespread adoption. Continuous technological improvements, including miniaturized surgeries and disposable ureteroscopes, further bolster the kidney stones treatment landscape. 

Get more information on Kidney Stones Therapeutic Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• End-user
  • Hospitals
  • Specialty clinics
  • Ambulatory surgical centers
• Type
  • Ureteroscopy
  • Lithotripsy
  • Percutaneous nephrolithonomy (PCNL)
• Therapy Area
  • Calcium oxalate stones
  • Uric acid
  • Struvite kidney stones
  • Cystine stones
  • Calcium phosphate stones
• Geography
  • North America
    • US
    • Canada
  • Europe
    • France
    • Germany
    • Italy
    • UK
  • Asia
  • Rest of World (ROW)
    • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Growing popularity of flexible digital ureteroscopes
• Rising incidence of urolithiasis among global population
• Increasing prevalence of kidney stone disease

However, the market also witnesses some limitations, which are as follows:

• Decreasing number of urologists coupled with shortage of skilled surgeons
• High cost of treatment
• Limitations and risk factors associated with kidney stone treatment procedures

Benefits of Buying Global Kidney Stones Therapeutic Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Kidney Stones Therapeutic Market Research Report

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

The Kidney Stones Therapeutic Market encompasses various innovative treatments, including endoscopic lithotripsy and holmium laser lithotripsy, as well as ureteral stents and nephrostomy tubes. Minimally invasive procedures like laparoscopic surgery, robotic surgery, and targeted therapies such as drug delivery, gene therapy, and stem cell therapy are also part of this market. Clinical pathways, evidence-based medicine, cost-benefit analysis, and health economics are essential aspects of kidney stone treatment. Patient-reported outcomes, quality-adjusted life years, health outcomes, and population health are key health indicators. Disease burden, healthcare disparities, access to care, health literacy, patient empowerment, patient advocacy, health insurance, payer relations, and medical tourism influence the market landscape.

Market Research Overview

The Kidney Stones Therapeutic Market, a segment of the larger global pharmaceuticals market, encompasses organizations involved in the research and development (R&D) or production of various types of drugs, including generic, non-generic, and veterinary. According to Technavio's market analysis, the healthcare industry's overall size is determined by the consolidated revenue generated by manufacturers and providers of medical equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services. The expansion of the pharmaceuticals market will be influenced by several key factors, including the increasing aging population. By 2050, approximately one-quarter of the US population and Europe's population ratio is projected to surpass 60 years old. This demographic shift will lead to a higher prevalence of kidney stones, driving demand for effective treatment options. Additionally, advanced procedures like percutaneous nephrolithotomy and open surgery, along with pain management solutions and calcium channel blockers, will play significant roles in addressing this health concern. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/